Megan Buri, MD | |
221 Bolivar St, Jefferson City, MO 65101-1572 | |
(720) 248-4483 | |
(720) 302-2659 |
Full Name | Megan Buri |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 8 Years |
Location | 221 Bolivar St, Jefferson City, Missouri |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922462795 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2016017320 (Missouri) | Primary |
208M00000X | Hospitalist | 2017034680 (Missouri) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used by less than 1 percent of people in the U.S., according to a new study published in the American Journal of Public Health.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants Manager® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times.
States around the country are taking advantage of a once little-used policy that allows them to bill Medicaid for the healthcare expenses of prisoners who leave a correctional institution for treatment. Since 1997, states have been allowed to bill Medicaid for the care of inmates who required treatment at a hospital or nursing facility for longer than 24 hours. The provision has drawn new attention this year as millions of Americans, including those serving time in correctional institutions, have become newly eligible for Medicaid under the Patient Protection and Affordable Care Act (Dickson, 9/23).
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
› Verified 7 days ago
Entity Name | Saint Lukes Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used by less than 1 percent of people in the U.S., according to a new study published in the American Journal of Public Health.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants Manager® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times.
States around the country are taking advantage of a once little-used policy that allows them to bill Medicaid for the healthcare expenses of prisoners who leave a correctional institution for treatment. Since 1997, states have been allowed to bill Medicaid for the care of inmates who required treatment at a hospital or nursing facility for longer than 24 hours. The provision has drawn new attention this year as millions of Americans, including those serving time in correctional institutions, have become newly eligible for Medicaid under the Patient Protection and Affordable Care Act (Dickson, 9/23).
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
› Verified 7 days ago
Entity Name | Kansas City Care Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215273388 PECOS PAC ID: 9335386168 Enrollment ID: O20130514000624 |
News Archive
Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used by less than 1 percent of people in the U.S., according to a new study published in the American Journal of Public Health.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants Manager® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times.
States around the country are taking advantage of a once little-used policy that allows them to bill Medicaid for the healthcare expenses of prisoners who leave a correctional institution for treatment. Since 1997, states have been allowed to bill Medicaid for the care of inmates who required treatment at a hospital or nursing facility for longer than 24 hours. The provision has drawn new attention this year as millions of Americans, including those serving time in correctional institutions, have become newly eligible for Medicaid under the Patient Protection and Affordable Care Act (Dickson, 9/23).
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Megan Buri, MD Po Box 10286, Kansas City, MO 64171-0286 Ph: () - | Megan Buri, MD 221 Bolivar St, Jefferson City, MO 65101-1572 Ph: (720) 248-4483 |
News Archive
Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used by less than 1 percent of people in the U.S., according to a new study published in the American Journal of Public Health.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants Manager® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times.
States around the country are taking advantage of a once little-used policy that allows them to bill Medicaid for the healthcare expenses of prisoners who leave a correctional institution for treatment. Since 1997, states have been allowed to bill Medicaid for the care of inmates who required treatment at a hospital or nursing facility for longer than 24 hours. The provision has drawn new attention this year as millions of Americans, including those serving time in correctional institutions, have become newly eligible for Medicaid under the Patient Protection and Affordable Care Act (Dickson, 9/23).
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
› Verified 7 days ago
Todd D Mccluskey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3308 W Edgewood Dr, Suite B, Jefferson City, MO 65109 Phone: 573-893-7848 Fax: 573-893-1984 | |
Craig Alan Luetkemeyer, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1014 Madison St, Jefferson City, MO 65101 Phone: 573-644-6999 Fax: 573-644-7880 | |
Dr. Michael G. Steenbergen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-634-7423 | |
Dr. James J. Weiss, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-634-7423 | |
Lorrie L Campbell, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1014 Madison St, Jefferson City, MO 65101 Phone: 573-644-6999 Fax: 573-644-7880 | |
Dr. Douglas N. Smith, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3308 W Edgewood Dr, Suite B, Jefferson City, MO 65109 Phone: 573-893-7848 Fax: 573-893-1984 | |
Michael Peter Dudenhoeffer, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 606 E High St, Jefferson City, MO 65101 Phone: 573-635-2211 Fax: 573-636-9350 |